Immunoreactive lysozyme was readily detectable in canine histiocytic disorders including systemic histiocytosis, malignant histiocytosis and granulomatous panniculitis. Lysozyme was less reliable as a histiocytic marker in cutaneous histiocytoma; forty percent of these tumors were negative for lysozyme expression. The marked heterogeneity in lysozyme expression in cutaneous histiocytoma may indicate that a proportion of these tumors show relatively primitive histiocytic differentiation and do not express lysozyme. Alternatively, this same proportion may exhibit a phenotype akin to cutaneous Langerhans cells which do not contain lysozyme. Lysozyme was not detectable in the tumor cells in lymphomatoid granulomatosis, atypical cutaneous histiocytoma, and histiocytic lymphosarcoma. Other evidence that these three disorders do not represent true histiocytic proliferative disorders is discussed.
The potential value of immunoreactive lysozyme as a histiocytic marker in normal canine tissues was evaluated in a previous paper. Lysozyme occurred within macrophages, although it was also found in monocytes, neutrophils, serous cells in exocrine glands associated with respiratory, alimentary and ocular mucosae, and renal proximal tubular epithelium. Not all cells identifiable as macrophages by their morphology, location, and enzyme cytochemical reactivity contained lysozyme. Also, dendritic antigen presenting cells, such as Langerhans cells, interdigitating reticulum cells and follicular dendritic cells, did not contain appreciable lysozyme. It was concluded that lysozyme was a useful adjunct to conventional morphological methods to identify macrophages, however, the absence of lysozyme in a cell did not preclude a histiocytic origin (P. F. Moore, data submitted) .
Serum lysozyme levels apparently reflect liberation of the enzyme by myeloid leukocytes and histiocytes. 5,6.8 Elevated serum lysozyme levels have been reported in myeloproliferative disorders, particularly those with monocytic or histiocytic differentiation and in granulomatous diseases such as tuberculosis, sarcoidosis, and Crohn's Lysozyme has been used as an immunohistochemical marker of histiocytic differentiation in human histiocytic proliferative and granulomatous d i~~r d e r~.~~~~~~~~~~~~~~~~
The infiltrating cells in these disorders contain immunoreactive lysozyme in many instances although lysozyme is not always readily demonstrable in disorders in which relatively primitive histiocytic differentiation is commonly e n c o~n t e r e d .~~~~~~~~ Utilization of lysozyme as an immunohistochemical marker for histiocytes in canine histiocytic disorders has been limited.22
The aim of the present study is to characterize the expression of immunoreactive lysozyme by the infiltrating cells in canine disorders in which histiocytic infiltration is known or suspected. These disorders include systemic histiocytosis, malignant histiocytosis, cutaneous histiocytoma, granulomatous (nodular) panniculitis, lymphomatoid granulomatosis, atypical cutaneous histiocytoma, and histiocytic lymphosarcoma.
Materials and Methods
Formalin-fixed paraffin-embedded tissues from all seven canine disorders were retrieved from the pathology files (Table 1). All cases of cutaneous histiocytoma and atypical cutaneous histiocytoma which occurred between 1983 and 1985 and all cases of the remaining disorders which occurred between 1975 and 1985 were evaluated. If surgical specimens were available for a case, they were used in preference to necropsy specimens since the former were more likely to have been freshly fixed and rapidly processed with minimal time spent in formalin. In regard to cases of atypical histiocytoma, cutaneous histiocytoma and granulomatous panniculitis, only surgical specimens were available for evaluation.
All potential cases for inclusion in the study were re-evaluated as to the appropriateness of the original diagnoses. Selection of cases was based largely on light microscopic morphological criteria previously described for systemic histiocytosis,20 malignant histiocytosis,22.26 cutaneous histiocytoma,13 granulomatous panni~ulitis,~~ lymphomatoid granu l o m a t o~i s , '~.~~ atypical cutaneous histiocytoma,19 and histiocytic lymphosarcoma.'0.26 In addition, five cases of systemic histiocytosis, nine cases of malignant histiocytosis, and four cases of atypical cutaneous histiocytoma were examined by electron microscopy for ultrastructural features of histiocytes. Sections from all cases of cutaneous histiocytoma were Moderate to intense positive staining of the majority of histiocytes Marked variation in staining intensity between individual tumor cells Intense, diffuse positive staining Regional positive staining Intense positive staining in the majority of macrophages; some were un-common stained * * * * Positive staining observed within intravascular leukocytes and a minor population of infiltrating cells most numerous either around vessels, at the periphery of the infiltrates, or within areas of necrosis (see results).
stained with toluidine blue to ensure that none of the cases were occult mast cell tumors. Sixteen of the nineteen cases of malignant histiocytosis, and six of the seven cases of systemic histiocytosis occurred in Bernese mountain dogs. Curiously, a systemic histiocytosis-like disorder was observed for the first time in a breed other than a Bernese mountain dog, in this instance, a 4-yearold male crossbred labrador.
Sections of all tissues used in the study were mounted on glue-coated slides (1% w/v Elmer's Glue-all, Borden). Sections were de-paraffinized and treated with 0.1% trypsin (Sigma Chemical Company, St. Louis, MO) and 0.1 Yo CaC1, in 0.02 M Tris buffered normal saline pH 7.8 for 40 minutes at 38 C. The trypsinization time was arrived at by titration as described previously (P. F. Moore, data submitted). Sections were then stained for lysozyme by an avidin-biotinperoxidase complex technique as described previously (P. F. Moore, data submitted) and were lightly counterstained with hematoxylin. A negative control was included for each section. It was treated identically except that appropriately diluted normal rabbit serum was substituted for the primary antiserum. A known positive section consisting of normal canine lung which contained alveolar macrophages was also included in each run. Sections were evaluated for lysozyme staining without knowledge of the diagnosis pertaining to each section. The appropriateness of the trypsinization procedure and lysozyme staining technique was assured in sections in which the infiltrating cells lacked demonstrable lysozyme by confirming that intravascular leukocytes exhibited positive staining.
Results
The morphological appearance of tissues after brief trypsin digestion and immunoperoxidase staining was comparable to that in routine paraffin sections. Intracytoplasmic lysozyme was readily detected by the presence of a blue-black precipitate at the site of antibody binding.
An overview of lysozyme immunoreactivity in disorders with a known or suspected histiocytic basis is presented in Table 1 . The perivascular, vasoinvasive histiocytic infiltrates in all cases of systemic histiocytosis stained intensely for lysozyme ( Fig. 5 ). The neoplastic infiltrates in 16 Bernese mountain dogs and two other dogs with malignant histiocytosis stained positively for lysozyme ( Fig. 4) although the incidence of staining of individual neoplastic cells in five tumors was low. In the latter instances the positively stained cells clearly possessed pleomorphic, hyperchromatic nuclei and other cytological features characteristic of the infiltrating tumor cells. A third dog had a massive splenic tumor which contained numerous, erythrophagocytic, multinucleated giant cells. The tumor cells in this case, which in other respects resembled malignant histiocytosis, were devoid of cytoplasmic lysozyme.
Infiltrating cells in cutaneous histiocytoma exhibited several distinct staining patterns. Of the 32 tumors examined, only 11 demonstrated intense, diffuse positive staining for lysozyme ( Fig. 2) . An additional eight tumors contained regions in which histiocytes were positively stained and interspersed with regions in which histiocytes were totally unstained. The remaining 13 tumors were unstained except for intravascular and perivascular aggregates of mononuclear cells which may have represented monocytes and infiltrating macrophages, respectively (Fig. 3 ). Marked differences in the intensity of staining were seen between individual cells even in tumors in which the majority of cells stained for lysozyme. Lymphocytic infiltrates were in all tumors. Lymphocytes were readily identified by their nuclear morphology and did not stain for lysozyme.
Infiltrating macrophages in dogs with granulomatous panniculitis were studied to determine if granuloma macrophages would continue to express lysozyme. Intensely positive macrophages were present in all lesions (Fig. 6) although not all macrophages contained lysozyme and others were only weakly stained. Variable numbers of neutrophils were also present and always stained intensely for lysozyme.
The vasoinvasive, cytologically atypical cells in the pulmonary infiltrates in six dogs with lymphomatoid granulomatosis did not contain demonstrable lysozyme (Fig. 1 ) although a minor population of cells which were most numerous at the periphery of the infiltrates stained positively for lysozyme. These cells closely resembled alveolar macrophages cytologically and probably represented normal infiltrating tumor macrophages. The unstained cells possessed large, pleomorphic, hyperchromatic ovoid nuclei and a high nuclear : cytoplasmic ratio which served to distinguish them from the positively stained cell population.
Lysozyme was not demonstrable in the infiltrating cells in all five dogs with atypical histiocytoma of skm, nor in all nine dogs with histiocytic lymphosarcoma of lymph nodes. Intravascular leukocytes and infrequent large cells within and adjacent to areas of necrosis were positively stained for lysozyme. The latter cells were presumed to represent tumor macrophages based on location, nuclear detail and nuclear: cytoplasmic ratio.
Discussion
Lysozyme was a valuable marker of histiocytic differentiation in systemic histiocytosis, malignant histiocytosis and granulomatous panniculitis, but was not demonstrable in the infiltrating tumor cells in forty percent of cases of cutaneous histiocytoma nor in all stained; some macrophages as well as the lymphocytes are unstained. Hematoxylin counterstain.
cases of lymphomatoid granulomatosis, atypical cutaneous histiocytoma, and histiocytic lymphosarcoma. In man, lysozyme is considered a good marker of histiocytic differentiation in granulomatous disord e r~; '~. '~,~~ it is also readily detected in myeloid leukocytes in myeloproliferative
The results of lysozyme staining have been quite variable in neoplastic histiocytic disorders such as malignant histiocytosis; very poorly differentiated cells are often devoid of and well differentiated cells often contain it.3,i1,'8 Lysozyme has not been useful as a histiocytic marker in histiocytosis X which is currently believed to represent a Langerhans cell proliferative disorder. Histiocytosis X cells, Langerhans cells, and other dendritic antigen presenting cells do not contain ly~ozyme.'.~ Hence, lack of lysozyme expression in tumor cells in a histiocytic disorder may either reflect primitive histiocytic differentiation or differentiation towards a dendritic antigen presenting cell phenotype.
Lysozyme was readily demonstrated within infiltrating cells in granulomatous panniculitis, and in systemic histiocytosis and malignant histiocytosis of Bernese mountain dogs as well as in similar disorders in other breeds. The infiltrating cells in the latter two disorders appeared to exhibit good histiocytic differentiation based on previous ultrastructural and enzyme cytochemical observations.20,22 Hence, it is not surprising that lysozyme was a good marker of histiocytic differentiation in both disorders. In five of the 19 cases of malignant histiocytosis only a minor population of cells contained appreciable lysozyme although even then it was obvious that those cells had nuclear and other cytological characteristics of the infiltrating tu-mor cells rather than of infiltrating normal macrophages. The observation that not all infiltrating tumor cells possessed lysozyme is not surprising based on the previously documented ultrastructural heterogeneity with respect to the degree of cytoplasmic differentiation that existed within these tumors. 22 The majority of histiocytes in cutaneous histiocytoma were strongly positive for lysozyme in only 35% of the tumors examined. A further 25% of the tumors exhibited marked regional variation characterized by domains of intensely positive cells within large areas of totally negative cells. Forty percent of the tumors were largely unstained. These results are unlikely to have been influenced by differences in fixation between tumors due to the fact that all were surgical specimens and intravascular and perivascular. Lysozyme-positive mononuclear cells were present in all tumors regardless of how the tumor cells stained. These results are better explained by hypothesizing that in some tumors a variable proportion of the cells are relatively more primitive and hence are less likely to synthesize lysozyme. Alternatively, it is possible that heterogeneity in lysozyme expression among infiltrating cells in cutaneous histiocytoma reflects differentiation toward one or more of the several mononuclear phagocyte phenotypic variants in these tumors. Similar heterogeneity was also demonstrated in histiocytes in normal canine tissues. Langerhans cells, follicular dendritic cells, and interdigitating reticulum cells did not contain appreciable lysozyme and many but not all macrophages in other tissues did (P. F. Moore, data submitted). It is possible that a proportion of histiocytomas contain cells which are more like Langerhans cells in pheno-type. Positive evidence for this notion is lacking in that Birbeck's granules, ultrastructural markers of Langerhans cells in man and rodents, have not been seen in the tumor cells in cutaneous histio~ytoma.~,~~ However, Birbeck's granules were not seen in an extensive study of dendritic cells in normal canine skin.21 Hence, the absence of Birbeck's granules in the tumor cells in cutaneous histiocytoma does not necessarily belie a Langerhans cell histogenesis. This situation will be more easily resolved when the enzyme cytochemical and immunohistochemical properties of canine Langerhans cells have been more thoroughly investigated. The status of lymphomatoid g r a n u l o m a t o~i~~~ of man as a disorder separate from polymorphic lymphoma has been questioned.* A recent immunohistochemical study indicated that lymphomatoid granulomatosis probably begins as a polyclonal lymphoproliferative disorder which later evolves into a monoclonal lymphoid proliferation. Neoplastic cells do not express histiocytic rnarkers.l2 Neoplastic cells in canine lymphomatoid granulomatosisI6 did not stain for lysozyme and lacked other identifying features of histiocytes such as evidence of phagocytosis and more appropriate nuclear: cytoplasmic ratio. Hence, it is possible that canine lymphomatoid granulomatosis also represents a lymphoproliferative process. However, this suggestion is based on negative evidence and as such is not definitive. There is clearly a need for further studies using fresh frozen tissue and live cells. The use of multiple immunohistochemical and enzyme cytochemical markers, ultrastructural observations and functional studies would allow a more precise definition of this disorder.
The failure to see lysozyme in the tumor cells in cutaneous atypical histiocytoma is consistent with the recent suggestion that at least some of these tumors are in fact Merkel cell tumors.19 The tumor cells in the cases presented herein did not possess the ultrastructural features of macrophages. Neurosecretory granules were not found in any of the tumors, hence their true histogenesis is uncertain.
Lysozyme was not demonstrable in the tumor cells in histiocytic lymphosarcoma, supporting previous work which suggested that these tumors were not likely of true histiocytic origin.'O This study has shown that lysozyme, although not specific for histiocytes, is a useful adjunct to conventional morphological methods in identifying histiocytes in systemic histiocytosis, malignant histiocytosis, and granulomatous panniculitis. Inability to demonstrate lysozyme in the infiltrating cells of a putative histiocytic process does not preclude a histiocytic origin since 40% of cutaneous histiocytomas totally lacked immunoreactive lysozyme. This and other evidence summarized within f u o r s the existence of heteroge-neity within normal and neoplastic canine mononuclear phagocyte populations with respect to lysozyme expression. 
